Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter

被引:93
作者
Han, HK [1 ]
Oh, DM [1 ]
Amidon, GL [1 ]
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
关键词
amino acid ester; Caco-2; cells; cellular uptake; peptide transporter; permeability; prodrugs;
D O I
10.1023/A:1011945420235
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose: This study characterized the cellular uptake mechanism and hydrolysis of the amino acid ester prodrugs of nucleoside antiviral drugs in the transiently transfected Caco-2 cells overexpressing: a human intestinal peptide transporter, hPEPT1 (Caco-2/hPEPT1 cells). Methods: Amino acid ester prodrugs of acyclovir and AZT were synthesized and their apical membrane permeability and hydrolysis were evaluated in Caco-2/hPEPT1 cells. The cellular uptake mechanism of prodrugs was investigated through the competitive inhibition study in Caco-2/hPEPT1 cells. Results: L-Valyl ester of acyclovir (L-Val-ACV) was approximately ten fold more permeable across the apical membrane than acyclovir and four times more permeable than D-valyl ester of acyclovir (D-Val-ACV). Correspondingly, L-valyl ester of AZT (L- VaI-AZT) exhibited three fold higher cellular uptake than AZT. Therefore, amino acid ester prodrugs significantly increased the cellular uptake of the parent drugs and exhibited the D,L-stereoselectivity. Furthermore, prodrugs were rapidly hydrolyzed to the parent drugs by the intracellular hydrolysis, following. the apical membrane transport. In the inhibition studies, cephalexin and small dipeptides strongly inhibited the cellular uptake of L-Val-ACV while L-valine had no effect, indicating that the peptide transporter is primarily responsible for the apical membrane transport of L-Val-ACV. In addition, the cellular uptake of L-Val-ACV was five rimes higher in Caco-2/hPEPT1 cells than the uptake in the untransfected Caco-2 cells, implying the cellular uptake of L-Var-ACV was related to the enhancement of the peptide transport activity in Caco-2/hPEPT1 cells. Conclusions: Caco-2/hPEPT1 system is an efficient in vitro model for the uptake study of peptidyl derivatives. Amino acid ester prodrugs significantly improved the cellular uptake of the parent drugs via peptide transport mechanism and were rapidly converted to the active parent drugs by the intracellular hydrolysis.
引用
收藏
页码:1382 / 1386
页数:5
相关论文
共 16 条
  • [1] AMINO-ACID ESTER PRODRUGS OF ACYCLOVIR
    BEAUCHAMP, LM
    ORR, GF
    DEMIRANDA, P
    BURNETTE, T
    KRENITSKY, TA
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (03) : 157 - 164
  • [2] In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system
    Chong, SH
    Dando, SA
    Soucek, KM
    Morrison, RA
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (01) : 120 - 123
  • [3] Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells
    Covitz, KMY
    Amidon, GL
    Sadee, W
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (11) : 1631 - 1634
  • [4] Han Hyokyung, 1996, Pharmaceutical Research (New York), V13, pS246
  • [5] HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736
  • [6] HSU MCP, IN PRESS OVEREXPRESS
  • [7] USE OF THE PEPTIDE CARRIER SYSTEM TO IMPROVE THE INTESTINAL-ABSORPTION OF L-ALPHA-METHYLDOPA - CARRIER KINETICS, INTESTINAL PERMEABILITIES, AND INVITRO HYDROLYSIS OF DIPEPTIDYL DERIVATIVES OF L-ALPHA-METHYLDOPA
    HU, M
    SUBRAMANIAN, P
    MOSBERG, HI
    AMIDON, GL
    [J]. PHARMACEUTICAL RESEARCH, 1989, 6 (01) : 66 - 70
  • [8] COMPARISON OF UPTAKE CHARACTERISTICS OF THYMIDINE AND ZIDOVUDINE IN A HUMAN INTESTINAL EPITHELIAL MODEL SYSTEM
    HU, M
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (08) : 829 - 833
  • [9] MOLECULAR-CLONING OF PEPT-2, A NEW MEMBER OF THE H+/PEPTIDE COTRANSPORTER FAMILY, FROM HUMAN KIDNEY
    LIU, W
    LIANG, R
    RAMAMOORTHY, S
    FEI, YJ
    GANAPATHY, ME
    HEDIGER, MA
    GANAPATHY, V
    LEIBACH, FH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1235 (02): : 461 - 466
  • [10] LOWRY OH, 1951, J BIOL CHEM, V193, P265